Publications

• Predictors of visual outcome in optic neuropathy of sarcoidosis.
  J Neuroimmunol Volume: 400 Page(s): 578529
  03/15/2025 Authors: Nakirikanti AS; El Sammak S; Tyor W; Hutto SK
• Neurosarcoidosis of the trigeminal nerve: clinical accompaniments, radiographic findings, and association with neuralgia.
  Neurol Sci Volume: 45 Page(s): 5889 - 5896
  12/01/2024 Authors: Hutto SK; Gandh AS; Tyor W
• The identification of intact HIV proviral DNA from human cerebrospinal fluid.
  Neurotherapeutics Volume: 21 Page(s): e00373
  07/01/2024 Authors: Zhang Z; Reece MD; Roa S; Tyor W; Franklin DR; Letendre SL; Marconi VC; Anderson AM; Gavegnano C
• Exploration of potential immune mechanisms in cervical dystonia.
  Parkinsonism Relat Disord Volume: 122 Page(s): 106036
  05/01/2024 Authors: Scorr LM; Kilic-Berkmen G; Sutcliffe DJ; Dinasarapu AR; McKay JL; Bagchi P; Powell MD; Boss JM; Cereb N; Little M
• Honokiol hexafluoro confers reversal of neuropathological markers of HIV infection in a murine SCID model.
  Neurotherapeutics Volume: 21 Page(s): e00329
  03/01/2024 Authors: Zhang Z; Scanlan A; Koneru R; Morrell CR; Reece MD; Edwards E; Roa S; Gavegnano C; Bimonte-Nelson H; Arbiser J
• A Rationale and Approach to the Development of Specific Treatments for HIV Associated Neurocognitive Impairment.
  Microorganisms Volume: 10
  11/12/2022 Authors: Scanlan A; Zhang Z; Koneru R; Reece M; Gavegnano C; Anderson AM; Tyor W
• Neurological Complications in Children Hospitalized With Seizures and Respiratory Infections: A Comparison Between SARS-CoV-2 and Other Respiratory Infections.
  Pediatr Neurol Volume: 135 Page(s): 52 - 55
  10/01/2022 Authors: Gombolay G; Anderson M; Xiang Y; Bai S; Rostad CA; Tyor W
• Immune responses to SARS-CoV-2 vaccination in multiple sclerosis: a systematic review/meta-analysis.
  Ann Clin Transl Neurol Volume: 9 Page(s): 1321 - 1331
  08/01/2022 Authors: Gombolay GY; Dutt M; Tyor W
• Novel method to quantify phenotypic markers of HIV-associated neurocognitive disorder in a murine SCID model.
  J Neurovirol Volume: 26 Page(s): 838 - 845
  12/01/2020 Authors: Gavegnano C; Haile W; Koneru R; Hurwitz SJ; Kohler JJ; Tyor WR; Schinazi RF
• HIV X4 Variants Increase Arachidonate 5-Lipoxygenase in the Pulmonary Microenvironment and are associated with Pulmonary Arterial Hypertension.
  Sci Rep Volume: 10 Page(s): 11696
  07/16/2020 Authors: Almodovar S; Wade BE; Porter KM; Smith JM; Lopez-Astacio RA; Bijli K; Kang B-Y; Cribbs SK; Guidot DM; Molehin D
• Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
  JAMA Neurol Volume: 77 Page(s): 480 - 488
  04/01/2020 Authors: Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M
• CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease.
  J Investig Med Volume: 68 Page(s): 321 - 330
  02/01/2020 Authors: Rosenthal JF; Hoffman BM; Tyor WR
• Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
  J Neurovirol Volume: 25 Page(s): 673 - 685
  10/01/2019 Authors: Rosenthal J; Tyor W
• Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro.
  J Neuroinflammation Volume: 16 Page(s): 182
  09/27/2019 Authors: Gavegnano C; Haile WB; Hurwitz S; Tao S; Jiang Y; Schinazi RF; Tyor WR
• Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder.
  Sci Rep Volume: 9 Page(s): 8733
  06/19/2019 Authors: Ozturk T; Kollhoff A; Anderson AM; Christina Howell J; Loring DW; Waldrop-Valverde D; Franklin D; Letendre S; Tyor WR; Hu WT
• CSF Cytokines in Aging, Multiple Sclerosis, and Dementia.
  Front Immunol Volume: 10 Page(s): 480
  01/01/2019 Authors: Hu WT; Howell JC; Ozturk T; Gangishetti U; Kollhoff AL; Hatcher-Martin JM; Anderson AM; Tyor WR
• HIV p24 antigen is quantifiable at low concentrations in human cerebrospinal fluid with digital ELISA and is associated with decreased neuropsychological performance (vol 67, pg 137, 2018)
  CLINICAL INFECTIOUS DISEASES Volume: 67 Page(s): 1313 - 1313
  10/15/2018 Authors: Anderson AM; Tyor WR; Mulligan MJ
• Reversing interferon-alpha neurotoxicity in a HIV-associated neurocognitive disorder mouse model.
  AIDS Volume: 32 Page(s): 1403 - 1411
  07/17/2018 Authors: Koneru R; Bimonte-Nelson H; Ciavatta V; Haile W; Elmore K; Ward J; Maroun L; Tyor WR
• Measurement of Human Immunodeficiency Virus p24 Antigen in Human Cerebrospinal Fluid With Digital Enzyme-Linked Immunosorbent Assay and Association With Decreased Neuropsychological Performance.
  Clin Infect Dis Volume: 67 Page(s): 137 - 140
  06/18/2018 Authors: Anderson AM; Tyor WR; Mulligan MJ; Waldrop-Valverde D; Lennox JL; Letendre SL
• A mouse model of HIV-associated neurocognitive disorders: a brain-behavior approach to discover disease mechanisms and novel treatments.
  J Neurovirol Volume: 24 Page(s): 180 - 184
  04/01/2018 Authors: Tyor WR; Bimonte-Nelson H
• In vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common Antiretrovirals.
  Neurochem Res Volume: 42 Page(s): 3220 - 3232
  11/01/2017 Authors: Ciavatta VT; Bichler EK; Speigel IA; Elder CC; Teng SL; Tyor WR; Garca PS
• Peroxisome proliferator-activated receptor- agonists attenuate biofilm formation by Pseudomonas aeruginosa.
  FASEB J Volume: 31 Page(s): 3608 - 3621
  08/01/2017 Authors: Bedi B; Maurice NM; Ciavatta VT; Lynn KS; Yuan Z; Molina SA; Joo M; Tyor WR; Goldberg JB; Koval M
• Update on disease-modifying therapies for multiple sclerosis.
  J Investig Med Volume: 65 Page(s): 883 - 891
  06/01/2017 Authors: Vargas DL; Tyor WR
• Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
  J Neurovirol Volume: 23 Page(s): 106 - 112
  02/01/2017 Authors: Anderson AM; Lennox JL; Mulligan MM; Loring DW; Zetterberg H; Blennow K; Kessing C; Koneru R; Easley K; Tyor WR
• Ppar gamma Agonists Attenuate Biofilm Formation By Pseudomonas AerugINOSa
  AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Volume: 195
  01/01/2017 Authors: Bedi B; Maurice NM; Ciavatta VT; Tyor WR; Yuan Z; Goldberg JB; Hart CM; Koval MH; Sadikot RT
• Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment.
  J Neurovirol Volume: 22 Page(s): 816 - 822
  12/01/2016 Authors: Anderson AM; Lennox JL; Nguyen ML; Waldrop-Valverde D; Tyor WR; Loring DW
• The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model.
  Neurobiol Dis Volume: 92 Page(s): 137 - 143
  08/01/2016 Authors: Haile WB; Gavegnano C; Tao S; Jiang Y; Schinazi RF; Tyor WR
• HIV latency reversal research and the potential effects on the central nervous system: is concern warranted?
  J Int AIDS Soc Volume: 19 Page(s): 21008
  01/01/2016 Authors: Anderson AM; Schinazi RF; Tyor WR
• Concentration-Dependent Dual Role of Thrombin in Protection of Cultured Rat Cortical Neurons.
  Neurochem Res Volume: 40 Page(s): 2220 - 2229
  11/01/2015 Authors: Garca PS; Ciavatta VT; Fidler JA; Woodbury A; Levy JH; Tyor WR
• Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients.
  J Mult Scler (Foster City) Volume: 2
  05/01/2015 Authors: Habib J; Deng J; Lava N; Tyor W; Galipeau J
• Interferon- induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor.
  J Interferon Cytokine Res Volume: 35 Page(s): 317 - 324
  04/01/2015 Authors: Kessing CF; Tyor WR
• The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse model.
  J Interferon Cytokine Res Volume: 34 Page(s): 510 - 517
  07/01/2014 Authors: Fritz-French C; Shawahna R; Ward JE; Maroun LE; Tyor WR
• Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model.
  J Neurovirol Volume: 20 Page(s): 9 - 17
  02/01/2014 Authors: Koneru R; Olive MF; Tyor WR
• Mumps and rubella.
  Volume: 123 Page(s): 591 - 600
  01/01/2014 Authors: Tyor W; Harrison T
• Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders.
  J Neurovirol Volume: 19 Page(s): 515 - 522
  12/01/2013 Authors: Tyor W; Fritz-French C; Nath A
• Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence.
  Retrovirology Volume: 10 Page(s): 61
  06/08/2013 Authors: Rao VR; Neogi U; Talboom JS; Padilla L; Rahman M; Fritz-French C; Gonzalez-Ramirez S; Verma A; Wood C; Ruprecht RM
• Morphine exposure during HIV encephalitis in SCID mice.
  Neurochem Res Volume: 37 Page(s): 2836 - 2841
  12/01/2012 Authors: Tyor WR; Hwang HY; Fritz-French C
• Interferon- (IFN) neurotoxicity.
  Cytokine Growth Factor Rev Volume: 23 Page(s): 7 - 14
  01/01/2012 Authors: Fritz-French C; Tyor W
• Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients.
  J Neuroimmunol Volume: 232 Page(s): 179 - 185
  03/01/2011 Authors: Smith AW; Doonan BP; Tyor WR; Abou-Fayssal N; Haque A; Banik NL
• Opiates Exacerbate Neuronal Damage in SCID Mice with HIV Encephalitis
  Volume: 76 Page(s): A433 - A433
  03/01/2011 Authors: Hwang HY; Padilla L; Fitting S; Hauser KF; Knapp P; Tyor WR
• Interferon-alpha causes neuronal dysfunction in encephalitis.
  J Neurosci Volume: 29 Page(s): 3948 - 3955
  03/25/2009 Authors: Sas AR; Bimonte-Nelson H; Smothers CT; Woodward J; Tyor WR
• Opiate Interactions in SCID Mice with HIV Encephalitis
  Volume: 72 Page(s): A199 - A199
  03/17/2009 Authors: Tyor WR; Sas A; Jones R; Xu R; Knapp PE; Hauser KF
• Intra-peritoneal injection of polyclonal anti-interferon alpha antibodies cross the blood brain barrier and neutralize interferon alpha.
  Neurochem Res Volume: 33 Page(s): 2281 - 2287
  11/01/2008 Authors: Sas A; Jones R; Tyor W
• HIV-1 clade-specific differences in the induction of neuropathogenesis.
  J Neurosci Volume: 28 Page(s): 10010 - 10016
  10/01/2008 Authors: Rao VR; Sas AR; Eugenin EA; Siddappa NB; Bimonte-Nelson H; Berman JW; Ranga U; Tyor WR; Prasad VR
• Morphine interactions with HIV encephalitis in SCID mice
  Volume: 64 Page(s): S62 - S62
  01/01/2008 Authors: Tyor WR; Jones RE; Hauser K; Sas AR
• Cognitive dysfunction in HIV encephalitic SCID mice correlates with levels of Interferon-alpha in the brain.
  AIDS Volume: 21 Page(s): 2151 - 2159
  10/18/2007 Authors: Sas AR; Bimonte-Nelson HA; Tyor WR
• Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients.
  J Neuroimmunol Volume: 190 Page(s): 139 - 145
  10/01/2007 Authors: Imam SA; Guyton MK; Haque A; Vandenbark A; Tyor WR; Ray SK; Banik NL
• Highly active antiretroviral therapy of cognitive dysfunction and neuronal abnormalities in SCID mice with HIV encephalitis.
  Exp Neurol Volume: 205 Page(s): 506 - 512
  06/01/2007 Authors: Cook-Easterwood J; Middaugh LD; Griffin WC; Khan I; Tyor WR
• Neurosarcoidosis.
  Curr Treat Options Neurol Volume: 9 Page(s): 161 - 168
  05/01/2007 Authors: Patel AV; Stickler DE; Tyor WR
• Chronic cocaine exposure in the SCID mouse model of HIV encephalitis.
  Brain Res Volume: 1134 Page(s): 214 - 219
  02/23/2007 Authors: Griffin WC; Middaugh LD; Tyor WR
• Neutralizing antibody to interferon-alpha treatment in SCID mice with HIV encephalitis
  Volume: 13 Page(s): 130 - 131
  01/01/2007 Authors: Tyor WR; Sas AR; Bimonte-Nelson H
• Calpain activity correlates with cytokine production in patients with multiple sclerosis (MS)
  Volume: 178 Page(s): 193 - 193
  09/01/2006 Authors: Guyton MK; Imam S; Das A; Haque A; Tyor WR; Ray SK; Banik NL
• Impact of opiate-HIV-1 interactions on neurotoxic signaling.
  J Neuroimmune Pharmacol Volume: 1 Page(s): 98 - 105
  03/01/2006 Authors: Hauser KF; El-Hage N; Buch S; Nath A; Tyor WR; Bruce-Keller AJ; Knapp PE
• Clade CHIV-1 encephalitis in SCID mice results in less cognitive dysfunction than clade B
  Volume: 12 Page(s): 82 - 82
  01/01/2006 Authors: Tyor WR; Rao V; Sas A; Bimonte H; Ranga U; Prasad V
• Clade CHIV-1 encephalitis in SCID mice is less severe than Clade B encephalitis
  Volume: 60 Page(s): S46 - S46
  01/01/2006 Authors: Tyor WR; Rao V; Sas A; Bimonte-Nelson H; Ranga U; Prasad V
• Molecular targets of opiate drug abuse in neuroAIDS.
  Neurotox Res Volume: 8 Page(s): 63 - 80
  10/01/2005 Authors: Hauser KF; El-Hage N; Buch S; Berger JR; Tyor WR; Nath A; Bruce-Keller AJ; Knapp PE
• Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis.
  J Neurosci Res Volume: 81 Page(s): 53 - 61
  07/01/2005 Authors: Guyton MK; Wingrave JM; Yallapragada AV; Wilford GG; Sribnick EA; Matzelle DD; Tyor WR; Ray SK; Banik NL
• Highly active antiretroviral therapy and human immunodeficiency virus encephalitis.
  Ann Neurol Volume: 57 Page(s): 795 - 803
  06/01/2005 Authors: Cook JE; Dasgupta S; Middaugh LD; Terry EC; Gorry PR; Wesselingh SL; Tyor WR
• Interferon-alpha in the pathogenesis of HIV encephalitis
  Volume: 64 Page(s): A409 - A409
  03/22/2005 Authors: Tyor WR; Sas A; Bimonte-Nelson H
• Changes in calpain expression in peripheral blood mononuclear cells from multiple sclerosis patients
  Volume: 90 Page(s): 50 - 50
  08/01/2004 Authors: Imam SA; Terry EC; Tyor WR; Ray SK; Banik NL
• Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
  Lancet Volume: 363 Page(s): 1607 - 1608
  05/15/2004 Authors: Vollmer T; Key L; Durkalski V; Tyor W; Corboy J; Markovic-Plese S; Preiningerova J; Rizzo M; Singh I
• Calpain activity and expression varies with severity of disease in multiple sclerosis
  Volume: 62 Page(s): A485 - A485
  04/13/2004 Authors: Imam SA; Tyor WR; Banik NL
• Highly active antiretroviral therapy in a SCID mouse model of HIV-encephalitis reduces neuropathology and viral load
  Volume: 62 Page(s): A409 - A410
  04/13/2004 Authors: Tyor WR; Cook JE; Griffin WC; Middaugh LD
• The severe combined immunodeficient (SCID) mouse model of human immunodeficiency virus encephalitis: deficits in cognitive function.
  J Neurovirol Volume: 10 Page(s): 109 - 115
  04/01/2004 Authors: Griffin WC; Middaugh LD; Cook JE; Tyor WR
• Neuropathological changes in a SCID mouse model of HIV-encephalitis after treatment with highly active antiretroviral therapy
  Volume: 18 Page(s): A460 - A460
  03/23/2004 Authors: Cook JE; Middaugh LD; Tyor WR
• Recombinant interferon-alpha-induced chorea and frontal subcortical dementia.
  Neurology Volume: 59 Page(s): 1821
  12/10/2002 Authors: Gilbert GJ
• Recombinant interferon-alpha-induced chorea and frontal subcortical dementia - To the editor
  NEUROLOGY Volume: 59 Page(s): 1821 - 1821
  12/10/2002 Authors: Zhang R; Tyor WR
• Predictors of short-term disease activity following a first clinical demyelinating event: analysis of the CHAMPS placebo group.
  Mult Scler Volume: 8 Page(s): 405 - 409
  10/01/2002
• Measurement of highly active antiretroviral therapy in mouse brain
  Volume: 52 Page(s): S91 - S91
  09/01/2002 Authors: Tyor WR; Cook J; Dasgupta S; Terry E; Middaugh L
• Therapeutic options in neurosarcoidosis.
  Expert Rev Neurother Volume: 2 Page(s): 703 - 708
  09/01/2002 Authors: Kaliszky Z; Walker A; Tyor WR
• Treatment of spinal cord impact injury in the rat with transforming growth factor-beta.
  J Neurol Sci Volume: 200 Page(s): 33 - 41
  08/15/2002 Authors: Tyor WR; Avgeropoulos N; Ohlandt G; Hogan EL
• Update on viral encephalitis.
  Curr Opin Neurol Volume: 14 Page(s): 369 - 374
  06/01/2001 Authors: Hinson VK; Tyor WR
• Acute multiple sclerosis characterized by extensive mononuclear phagocyte infiltration.
  Neurochem Res Volume: 25 Page(s): 1517 - 1520
  11/01/2000 Authors: Shields DC; Avgeropoulos NG; Banik NL; Tyor WR
• Malignant multiple sclerosis characterized by extensive mononuclear phagocyte infiltration.
  Volume: 74 Page(s): S14 - S14
  01/01/2000 Authors: Shields DC; Avgeropoulos NG; Banik NL; Tyor WR
• Immunohistochemical localization of kininogen in rat spinal cord and brain.
  Exp Neurol Volume: 159 Page(s): 528 - 537
  10/01/1999 Authors: Li Z; Tyor WR; Xu J; Chao J; Hogan EL
• Interferon beta-1b and childhood multiple sclerosis.
  Pediatr Neurol Volume: 21 Page(s): 481 - 483
  07/01/1999 Authors: Adams AB; Tyor WR; Holden KR
• Do alcohol and cocaine abuse alter the course of HIV-associated dementia complex?
  J Leukoc Biol Volume: 65 Page(s): 475 - 481
  04/01/1999 Authors: Tyor WR; Middaugh LD
• Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis.
  Proc Natl Acad Sci U S A Volume: 95 Page(s): 5768 - 5772
  05/12/1998 Authors: Shields DC; Tyor WR; Deibler GE; Hogan EL; Banik NL
• SCID mice with HIV encephalitis develop behavioral abnormalities.
  J Acquir Immune Defic Syndr Hum Retrovirol Volume: 18 Page(s): 13 - 20
  05/01/1998 Authors: Avgeropoulos N; Kelley B; Middaugh L; Arrigo S; Persidsky Y; Gendelman HE; Tyor WR
• Transforming growth factor-beta treatment of spinal cord injury in the rat
  Volume: 50 Page(s): A258 - A259
  04/01/1998 Authors: Tyor WR; Ohlandt G; Avgeropoulos NG; Wright S; Wood R; Hogan EL
• Increased calpain expression in experimental demyelinating optic neuritis: an immunocytochemical study.
  Brain Res Volume: 784 Page(s): 299 - 304
  02/16/1998 Authors: Shields DC; Tyor WR; Deibler GE; Banik NL
• Long-term intracranial cannula stabilization in mice with light cured resin composites.
  J Neurosci Methods Volume: 79 Page(s): 31 - 36
  01/31/1998 Authors: Groseclose CH; Draughn RA; Tyor WR; Sallee FR; Middaugh LD
• Potential relationships between the presence of HIV, macrophages, and astrogliosis in SCID mice with HIV encephalitis.
  J NeuroAIDS Volume: 2 Page(s): 1 - 20
  01/01/1998 Authors: Avgeropoulos NG; Burris GW; Ohlandt GW; Wesselingh SL; Markham RB; Tyor WR
• Transforming growth factor-beta (TGF beta) treatment of spinal cord injury (SCI) in the rat
  Volume: 70 Page(s): S67 - S67
  01/01/1998 Authors: Tyor WR; Ohlandt G; Avgeropoulos N; Wright S; Wood R; Hogan EL
• Transforming growth factor-beta1 in adult human microglia and its stimulated production by interleukin-1.
  J Interferon Cytokine Res Volume: 17 Page(s): 655 - 664
  11/01/1997 Authors: da Cunha A; Jefferson JJ; Tyor WR; Glass JD; Jannotta FS; Cottrell JR; Resau JH
• The role of antibody in recovery from alphavirus encephalitis.
  Immunol Rev Volume: 159 Page(s): 155 - 161
  10/01/1997 Authors: Griffin D; Levine B; Tyor W; Ubol S; Desprs P
• Human immunodeficiency virus encephalitis in SCID mice.
  Am J Pathol Volume: 149 Page(s): 1027 - 1053
  09/01/1996 Authors: Persidsky Y; Limoges J; McComb R; Bock P; Baldwin T; Tyor W; Patil A; Nottet HS; Epstein L; Gelbard H
• Cocaine/sex type effects on T lymphocytes: a preliminary report.
  Drug Chem Toxicol Volume: 19 Page(s): 109 - 119
  01/01/1996 Authors: Xu W; Tyor WR; Middaugh LD; Boggan WO
• A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia.
  Brain Behav Immun Volume: 9 Page(s): 366 - 377
  12/01/1995 Authors: Rho MB; Wesselingh S; Glass JD; McArthur JC; Choi S; Griffin J; Tyor WR
• Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy.
  J Acquir Immune Defic Syndr Hum Retrovirol Volume: 9 Page(s): 379 - 388
  08/01/1995 Authors: Tyor WR; Wesselingh SL; Griffin JW; McArthur JC; Griffin DE
• HIV ENCEPHALITIS IN SCID MICE - REFLECTIONS OF THE HUMAN CONDITION
  Volume: 36 Page(s): 300 - 300
  08/01/1994 Authors: TYOR WR; MARKHAM R; MORAN T; POWER C; DETTENHOFER M; OHLANDT G
• HIV myelopathy.
  Neurology Volume: 44 Page(s): 578 - 579
  03/01/1994 Authors: Fuchs D; Murr C; Reibnegger G; Wachter H
• HIV MYELOPATHY - REPLY
  NEUROLOGY Volume: 44 Page(s): 578 - 579
  03/01/1994 Authors: TYOR WR; GRIFFIN DE
• Age-dependent susceptibility to fatal encephalitis: alphavirus infection of neurons.
  Arch Virol Suppl Volume: 9 Page(s): 31 - 39
  01/01/1994 Authors: Griffin DE; Levine B; Tyor WR; Tucker PC; Hardwick JM
• Cytokine expression and pathogenesis in AIDS brain.
  Res Publ Assoc Res Nerv Ment Dis Volume: 72 Page(s): 203 - 222
  01/01/1994 Authors: Vitkovic L; da Cunha A; Tyor WR
• Control of astrocytosis by interleukin-1 and transforming growth factor-beta 1 in human brain.
  Brain Res Volume: 631 Page(s): 39 - 45
  12/17/1993 Authors: da Cunha A; Jefferson JJ; Tyor WR; Glass JD; Jannotta FS; Vitkovi L
• Virus specificity and isotype expression of intraparenchymal antibody-secreting cells during Sindbis virus encephalitis in mice.
  J Neuroimmunol Volume: 48 Page(s): 37 - 44
  10/01/1993 Authors: Tyor WR; Griffin DE
• A model of human immunodeficiency virus encephalitis in scid mice.
  Proc Natl Acad Sci U S A Volume: 90 Page(s): 8658 - 8662
  09/15/1993 Authors: Tyor WR; Power C; Gendelman HE; Markham RB
• Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia.
  Ann Neurol Volume: 33 Page(s): 576 - 582
  06/01/1993 Authors: Wesselingh SL; Power C; Glass JD; Tyor WR; McArthur JC; Farber JM; Griffin JW; Griffin DE
• Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy.
  Neurology Volume: 43 Page(s): 1002 - 1009
  05/01/1993 Authors: Tyor WR; Glass JD; Baumrind N; McArthur JC; Griffin JW; Becker PS; Griffin DE
• Gliosis in human brain: relationship to size but not other properties of astrocytes.
  Brain Res Volume: 600 Page(s): 161 - 165
  01/08/1993 Authors: da Cunha A; Jefferson JJ; Tyor WR; Glass JD; Jannotta FS; Vitkovic L
• Long term intraparenchymal Ig secretion after acute viral encephalitis in mice.
  J Immunol Volume: 149 Page(s): 4016 - 4020
  12/15/1992 Authors: Tyor WR; Wesselingh S; Levine B; Griffin DE
• Macrophage responses and myelin clearance during Wallerian degeneration: relevance to immune-mediated demyelination.
  J Neuroimmunol Volume: 40 Page(s): 153 - 165
  10/01/1992 Authors: Griffin JW; George R; Lobato C; Tyor WR; Yan LC; Glass JD
• Chronic demyelinating polyneuropathy associated with eosinophilia-myalgia syndrome.
  J Neurol Neurosurg Psychiatry Volume: 55 Page(s): 352 - 358
  05/01/1992 Authors: Freimer ML; Glass JD; Chaudhry V; Tyor WR; Cornblath DR; Griffin JW; Kuncl RW
• The immune response in viral encephalitis.
  Semin Immunol Volume: 4 Page(s): 111 - 119
  04/01/1992 Authors: Griffin DE; Levine B; Tyor WR; Irani DN
• Cytokine expression in the brain during the acquired immunodeficiency syndrome.
  Ann Neurol Volume: 31 Page(s): 349 - 360
  04/01/1992 Authors: Tyor WR; Glass JD; Griffin JW; Becker PS; McArthur JC; Bezman L; Griffin DE
• ENTRY AND RETENTION OF VIRUS-SPECIFIC AND NONSPECIFIC B-CELLS DURING SINDBIS VIRUS ENCEPHALITIS IN MICE
  Volume: 5 Page(s): A1094 - A1094
  03/15/1991 Authors: TYOR WR; GRIFFIN DE
• The characterization of Ia expression during Sindbis virus encephalitis in normal and athymic nude mice.
  J Neuropathol Exp Neurol Volume: 49 Page(s): 21 - 30
  01/01/1990 Authors: Tyor WR; Stoll G; Griffin DE
• Macrophage responses in inflammatory demyelinating neuropathies.
  Ann Neurol Volume: 27 Suppl Page(s): S64 - S68
  01/01/1990 Authors: Griffin JW; Stoll G; Li CY; Tyor W; Cornblath DR
• Characterization of the local and systemic B cell response of normal and athymic nude mice with Sindbis virus encephalitis.
  J Neuroimmunol Volume: 24 Page(s): 207 - 215
  10/01/1989 Authors: Tyor WR; Moench TR; Griffin DE
• Characterization of B cells and IA expression in Sindbis virus encephalitis.
  Ann N Y Acad Sci Volume: 540 Page(s): 491 - 492
  01/01/1988 Authors: Tyor WR; Moench TR; Griffin DE
• LYMPHOCYTES-B DIFFERENTIATION AND IA-EXPRESSION IN SINDBIS VIRUS ENCEPHALITIS OF MICE
  JOURNAL OF NEUROIMMUNOLOGY Volume: 16 Page(s): 175 - 175
  09/01/1987 Authors: TYOR WR; MOENCH TR; GRIFFIN DE